Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Stroke Rate after CABG vs PCI in over 10,000 Patients

Repeat revascularization rate has historically been the weak spot of PCI when compared against CABG: we are still unable to compete with a well done internal mammary artery graft connected to the anterior descending artery.

Tasa de stroke post cirugía vs angioplastia coronaria en un análisis de más de 10.000 pacientesHowever, repeat revascularization is the soft of end points commonly assessed in trials, and even though several studies have shown the kind of patients that most benefit from CABG in terms of death or infarction, stroke has traditionally been overlooked. Most likely, the reason we lack data on one of the hardest end points is because it is not as frequent, which is why we need a larger population, to be able to show significant differences between these strategies.

 

This pooled analysis including 11518 patients (5573 PCI and 5765 CABG) from 11 randomized studies, showed that at 5 years stroke rate is significantly lower with PCI. The advantage seems to be driven by periprocedural stroke common to CABG, seeing as from 30 days and up to 5 years after procedure curves remain parallel. This kind of strokes are associated to higher mortality post procedure.


Read also: Endovascular Therapy in Stroke: Much Evidence and Few Trained Operators.


The pooled analysis included old studies such as the ERACL, ARTS or MASS II, classic studies such as the SYNTAX or the FREEDOM, and more contemporary studies such as the EXCEL and NOBLE.

 

At 30 days, stroke rate was 0.4% in the PCI group, and 1.1% with CABG (HR 0.33, CI 95% 0.20 to 0.53; p<0.001).

 

At 5 year follow up, stroke rate continued to be significantly lower in the PCI group (2.6% vs. 3.2%; p=0.027), even though between day 31 and 5 years, the incidence was comparable (2.2% vs 2.1%; p=072). There were no significant interactions between baseline characteristics and stroke with the sole exception of diabetes, where patients receiving PCI were especially benefitted. (2.6% vs 4.9%).


Read also: The Dangerous Combination of Complex Angioplasty and High Bleeding Risk Seems to Have a Solution.


Patients suffering from stroke within 30 days after index procedure had higher mortality both with PCI (45.7% vs 11.1%, p<0.001) and CABG (41.5% vs. 8.9%, p<0.001).

 

Conclusion

This analysis is one of the largest and most representative randomized studies to compare PCI against CABG, and with a 5 year follow up it has shown that stroke is significantly lower in patients undergoing PCI, driven by a reduced risk within 30 days after procedure, seeing as after 30 days and up to 5 years later, curves remain identical. The greatest risk of stroke in CABG patients was observed with multiple vessels disease and diabetes. Presenting stroke increased mortality at follow up regardless the strategy.

 

Original title: Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.

Reference: Stuart J. Head et al. J Am Coll Cardiol 2018;72:386–98.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...